SCHEMBL16620484

SCHEMBL16620484

Cc1ccc(NC(=O)N[C@H]2CCN(c3ccnc(N)n3)C2)cc1Cl

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCNC P24863 14/20 0.78
CDK8 P49336 14/20 0.78
CA12 O43570 2/20 0.56
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
CA4 P22748 2/20 0.56
CA7 P43166 2/20 0.56
CA9 Q16790 2/20 0.56
NPC1 O15118 1/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
EPHX2 P34913 1/20 0.53
BTK Q06187 1/20 0.53
BPTF Q12830 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16620489 1.00 CCNC (0.78) CCNCCDK8CA12CA1CA2
SCHEMBL16629102 0.88 CDK8 (1.00) CCNCCDK8BPTF
SCHEMBL16620237 0.88 CDK8 (1.00) CCNCCDK8BPTF
SCHEMBL16620231 0.88 CDK8 (1.00) CCNCCDK8BPTF
SCHEMBL16620517 0.85 CDK8 (1.00) CCNCCDK8CA12CA1CA2
SCHEMBL16629099 0.85 CDK8 (1.00) CCNCCDK8CA12CA1CA2
SCHEMBL16620519 0.85 CDK8 (1.00) CCNCCDK8CA12CA1CA2
SCHEMBL20445941 0.79 CCNC (0.57) CCNCCDK8BTK
SCHEMBL16620028 0.76 CDK8 (0.80) CCNCCDK8BPTF
SCHEMBL16620147 0.76 CDK8 (0.80) CCNCCDK8BPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO claimed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed